Filed: 11/14/2025ACC: 0001104659-25-112509
📋 What this filing means
FORESITE CAPITAL MANAGEMENT VI LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $258.87M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$258.87M
Total AUM (reported)
16.24M
Total Shares
Allocation by class
COM$218.75M84.5%
SPONSORED ADS$31.86M12.3%
CL A$6.63M2.6%
ORD SHS$1.63M0.6%
Portfolio Concentration
Top 3$161.64M62.4%
4–10$93.85M36.3%
11–25$3.37M1.3%
Top 3 weight
62.4%
Top 10 weight
98.7%
Voting Authority Distribution
Total shares with voting rights: 16.24M
Sole
Full voting authority
16.24M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
CG Oncology, Inc.
SOLEShares2.22M
TypeSH
Market value$89.48M
34.57%
Sole
2.22M
Shared
0.00
None
0.00
RAPT Therapeutics, Inc.
SOLEShares1.56M
TypeSH
Market value$40.30M
15.57%
Sole
1.56M
Shared
0.00
None
0.00
Centessa Pharmaceuticals plc
SOLEShares1.31M
TypeSH
Market value$31.86M
12.31%
Sole
1.31M
Shared
0.00
None
0.00
Verastem, Inc.
SOLEShares2.62M
TypeSH
Market value$23.09M
8.92%
Sole
2.62M
Shared
0.00
None
0.00
ALUMIS INC.
SOLEShares4.25M
TypeSH
Market value$16.95M
6.55%
Sole
4.25M
Shared
0.00
None
0.00
Denali Therapeutics Inc.
SOLEShares1M
TypeSH
Market value$14.52M
5.61%
Sole
1M
Shared
0.00
None
0.00
Corvus Pharmaceuticals, Inc.
SOLEShares1.73M
TypeSH
Market value$12.76M
4.93%
Sole
1.73M
Shared
0.00
None
0.00
Akero Therapeutics, Inc.
SOLEShares244.90K
TypeSH
Market value$11.63M
4.49%
Sole
244.90K
Shared
0.00
None
0.00
Kymera Therapeutics, Inc.
SOLEShares146.33K
TypeSH
Market value$8.28M
3.20%
Sole
146.33K
Shared
0.00
None
0.00
Hinge Health, Inc.
SOLEShares135K
TypeSH
Market value$6.63M
2.56%
Sole
135K
Shared
0.00
None
0.00
Avidity Biosciences, Inc.
SOLEShares40K
TypeSH
Market value$1.74M
0.67%
Sole
40K
Shared
0.00
None
0.00
CASI Pharmaceuticals, Inc.
SOLEShares979.96K
TypeSH
Market value$1.63M
0.63%
Sole
979.96K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG Oncology, Inc.SOLE | COM | 2.22M | SH | $89.48M 34.57% | 2.22M | 0.00 | 0.00 |
RAPT Therapeutics, Inc.SOLE | COM | 1.56M | SH | $40.30M 15.57% | 1.56M | 0.00 | 0.00 |
Centessa Pharmaceuticals plcSOLE | SPONSORED ADS | 1.31M | SH | $31.86M 12.31% | 1.31M | 0.00 | 0.00 |
Verastem, Inc.SOLE | COM | 2.62M | SH | $23.09M 8.92% | 2.62M | 0.00 | 0.00 |
ALUMIS INC.SOLE | COM | 4.25M | SH | $16.95M 6.55% | 4.25M | 0.00 | 0.00 |
Denali Therapeutics Inc.SOLE | COM | 1M | SH | $14.52M 5.61% | 1M | 0.00 | 0.00 |
Corvus Pharmaceuticals, Inc.SOLE | COM | 1.73M | SH | $12.76M 4.93% | 1.73M | 0.00 | 0.00 |
Akero Therapeutics, Inc.SOLE | COM | 244.90K | SH | $11.63M 4.49% | 244.90K | 0.00 | 0.00 |
Kymera Therapeutics, Inc.SOLE | COM | 146.33K | SH | $8.28M 3.20% | 146.33K | 0.00 | 0.00 |
Hinge Health, Inc.SOLE | CL A | 135K | SH | $6.63M 2.56% | 135K | 0.00 | 0.00 |
Avidity Biosciences, Inc.SOLE | COM | 40K | SH | $1.74M 0.67% | 40K | 0.00 | 0.00 |
CASI Pharmaceuticals, Inc.SOLE | ORD SHS | 979.96K | SH | $1.63M 0.63% | 979.96K | 0.00 | 0.00 |